CDEK by Data4ThePeople
Sign in Sign up
← All organizations

ImmunityBio, Inc.

For profitWebsite ↗

Also known as: Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc. | ImmunityBio, Inc.

Phase 1Phase 2Phase 3Phase 4

First clinical trial

May 11, 2020

Last known activity

Dec 31, 2025

Acquired by NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks on Dec 21, 2020

Timeline

2010s

  1. Jun 1, 2014

    ImmunityBio, Inc.— Founded

2020s

  1. Dec 21, 2020

    NantWorks— Acquired By

  2. Dec 21, 2020

    NantWorks— Now

  3. Dec 21, 2020

    NantCell, Inc.— Acquired

  4. Dec 21, 2020

    NantWorks— Acquired

Drugs by trial phase (83 distinct, 106 trials)

Indications

Studied for

Subsidiaries (2 direct, 62 total across the full acquisition tree)

Recent trials (38)

Details

Founded
Culver City, CA, US Jun 1, 2014
Last known activity
Dec 31, 2025